What is Alkem Laboratories Limited (ALKEM) share price today?

Alkem Laboratories Limited (ALKEM) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/ALKEM for the latest live price, technical analysis, and AI-powered insights.

How to analyse ALKEM stock?

VestAI provides comprehensive ALKEM stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Alkem Laboratories Limited in?

Alkem Laboratories Limited (ALKEM) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Alkem Laboratories Limited

Name: Alkem Laboratories Limited (ALKEM) Financial Metrics
Creator: VestAI
License: https://www.vestai.io/terms

ALKEM

NSE· Healthcare

₹5,651.50

+38.50 (+0.69%)

52W Low · ₹4,738.5052W High · ₹5,933.50

Near 52W High

Market Cap

₹67356.94L Cr

Volume

58.8K

Prev Close

₹5,633.50

ISIN

INE540L01014

Orion Score

Fundamentals-based quality & risk · not a recommendation

68/100

Quality

Alkem Laboratories Limited scores 68/100 (Quality) on the Orion Score — strong business quality (72), moderate growth (68), strong balance-sheet safety (81) and rich valuation (39). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.8× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 4/9Altman Z Safe(7.53)Beneish M Clean(-2.30)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

48/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.14x — lean balance sheet

QUALITY

Average

ROCE 16.3% — decent returns

MOMENTUM

Neutral

RSI 53.2 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 29.23
ROCE: 16.30%
ROE (1Y): 17.56%
D/E Ratio: 0.14x
OPM: 11.42%
TTM EPS: ₹192.71
Dividend Yield: 36.00%
Qtrly Sales: ₹3,603.32 Cr
Qtrly Profit: ₹236.46 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹3,603.32	₹236.46	11.4%	₹19.77
Q3 2026	₹3,736.82	₹636.02	19.6%	₹53.19
Q2 2026	₹4,000.99	₹765.06	20.7%	₹63.99
Q1 2026	₹3,371.14	₹664.26	19.3%	₹55.56
Q4 2025	₹3,143.75	₹305.86	8.9%	₹25.57

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹12,804.62	₹2,165.48	₹2,971.43	17.1%
FY 2024	₹12,439.24	₹1,795.77	₹2,418.14	16.0%
FY 2023	₹11,440.35	₹984.17	₹1,708.94	11.7%
FY 2022	₹10,512.03	₹1,645.62	₹2,189.08	16.8%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
ALKEM ★	₹67,357 Cr	29.23	16.30%	17.56%	0.14x	11.42%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹88,148 Cr	25.39	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹68,390 Cr	104.34	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,509 Cr	38.28	36.31%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹17,691.1	₹15,574.9	₹13,756.65	₹14,069.19
Equity	₹11,984.87	₹10,312.06	₹9,045.29	₹8,637.9
Total Debt	₹1,380.9	₹1,418.41	₹1,396.68	₹2,668.19
Cash	₹304.14	₹455.07	₹273.8	₹232.18
Net Debt	₹758.65	₹758.9	₹1,033.35	₹2,347.94
Working Capital	₹6,980.84	₹6,417.03	₹5,022.53	₹3,630.09

Shareholding Pattern

Q1 FY2027

Promoter

62.91%

FII

13.97%

DII

11.43%

Public

11.69%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	62.91%	13.97% ↑	11.43% ↑	11.69% ↓
Q4 FY2026	62.91% ↑	13.73% ↑	11.23% ↓	12.13% ↓
Q3 FY2026	51.2%	9.97% ↑	21.54% ↓	17.3% ↓
Q2 FY2026	51.2% ↓	9.47% ↑	21.93% ↑	17.39% ↑
Q1 FY2026	53.04% ↓	9.11% ↓	21.8% ↑	16.05%
Q4 FY2025	55.13% ↓	9.4% ↓	19.42% ↑	16.05% ↓
Q3 FY2025	55.66%	10.14% ↑	18.01% ↓	16.19% ↑
Q2 FY2025	55.66%	9.02%	19.21%	16.12%

Corporate Actions

Ex-Date	Action	Details
2026-02-20	DIVIDEND	Interim Dividend - Rs 43 Per Share

Funds Holding This Stock

139 mutual fund schemes

Tata Nifty MidSmall Healthcare Index Fund Direct GrowthTATA

5.35%

₹9 Cr

Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct GrowthMOTILAL_OSWAL

5.34%

₹2 Cr

HDFC Pharma And Healthcare Fund Direct GrowthHDFC

4.36%

₹103 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

4.08%

₹263 Cr

Samco Flexi Cap Fund Direct GrowthSamco MF

4.07%

₹12 Cr

Motilal Oswal Nifty MidSmall India Consumption Index Fund Direct GrowthMOTILAL_OSWAL

3.74%

₹1 Cr

ICICI Prudential Nifty Pharma Index Fund Direct GrowthICICI_PRUDENTIAL

3.60%

₹5 Cr

Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

3.57%

₹110 Cr

NJ Flexi Cap Fund Direct GrowthNJ

3.48%

₹89 Cr

NJ ELSS Tax Saver Scheme Direct GrowthNJ

3.28%

₹11 Cr

Analyse ALKEM with Orion AI

Ask: "Is Alkem Laboratories Limited stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Alkem Laboratories Limited (ALKEM) Stock

Alkem Laboratories Limited is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE540L01014. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.